These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1861 related items for PubMed ID: 19687708

  • 21. Apo2l/Tumor necrosis factor-related apoptosis-inducing ligand prevents breast cancer-induced bone destruction in a mouse model.
    Thai le M, Labrinidis A, Hay S, Liapis V, Bouralexis S, Welldon K, Coventry BJ, Findlay DM, Evdokiou A.
    Cancer Res; 2006 May 15; 66(10):5363-70. PubMed ID: 16707463
    [Abstract] [Full Text] [Related]

  • 22. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
    Zhao L, Dong A, Gu J, Liu Z, Zhang Y, Zhang W, Wang Y, He L, Qian C, Qian Q, Liu X.
    Cancer Gene Ther; 2006 Nov 15; 13(11):1011-22. PubMed ID: 16799468
    [Abstract] [Full Text] [Related]

  • 23. Combination of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and canstatin gene suppression therapy on breast tumor xenograft growth in mice.
    Wang WB, Zhou YL, Heng DF, Miao CH, Cao YL.
    Breast Cancer Res Treat; 2008 Jul 15; 110(2):283-95. PubMed ID: 17899369
    [Abstract] [Full Text] [Related]

  • 24. TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.
    Xia L, Peng R, Leng W, Jia R, Zeng X, Yang X, Fan M.
    J Dent Res; 2015 Jan 15; 94(1):219-28. PubMed ID: 25391621
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic efficacy and safety of TRAIL-producing human adipose tissue-derived mesenchymal stem cells against experimental brainstem glioma.
    Choi SA, Hwang SK, Wang KC, Cho BK, Phi JH, Lee JY, Jung HW, Lee DH, Kim SK.
    Neuro Oncol; 2011 Jan 15; 13(1):61-9. PubMed ID: 21062796
    [Abstract] [Full Text] [Related]

  • 26. Enhanced apoptosis and tumor regression induced by a direct agonist antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2.
    Motoki K, Mori E, Matsumoto A, Thomas M, Tomura T, Humphreys R, Albert V, Muto M, Yoshida H, Aoki M, Tamada T, Kuroki R, Yoshida H, Ishida I, Ware CF, Kataoka S.
    Clin Cancer Res; 2005 Apr 15; 11(8):3126-35. PubMed ID: 15837769
    [Abstract] [Full Text] [Related]

  • 27. Expression and antitumor effects of TRAIL in human cholangiocarcinoma.
    Tanaka S, Sugimachi K, Shirabe K, Shimada M, Wands JR.
    Hepatology; 2000 Sep 15; 32(3):523-7. PubMed ID: 10960444
    [Abstract] [Full Text] [Related]

  • 28. Role of tumor necrosis factor-related apoptosis-inducing ligand in immune response to influenza virus infection in mice.
    Ishikawa E, Nakazawa M, Yoshinari M, Minami M.
    J Virol; 2005 Jun 15; 79(12):7658-63. PubMed ID: 15919918
    [Abstract] [Full Text] [Related]

  • 29. Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice.
    Xiang H, Nguyen CB, Kelley SK, Dybdal N, Escandón E.
    Drug Metab Dispos; 2004 Nov 15; 32(11):1230-8. PubMed ID: 15282212
    [Abstract] [Full Text] [Related]

  • 30. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.
    Jin H, Yang R, Fong S, Totpal K, Lawrence D, Zheng Z, Ross J, Koeppen H, Schwall R, Ashkenazi A.
    Cancer Res; 2004 Jul 15; 64(14):4900-5. PubMed ID: 15256461
    [Abstract] [Full Text] [Related]

  • 31. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas.
    Park SA, Ryu CH, Kim SM, Lim JY, Park SI, Jeong CH, Jun JA, Oh JH, Park SH, Oh W, Jeun SS.
    Int J Oncol; 2011 Jan 15; 38(1):97-103. PubMed ID: 21109930
    [Abstract] [Full Text] [Related]

  • 32. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S, Stackhouse MA, Kaliberova L, Zhou T, Buchsbaum DJ.
    Gene Ther; 2004 Apr 15; 11(8):658-67. PubMed ID: 14973547
    [Abstract] [Full Text] [Related]

  • 33. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.
    Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385
    [Abstract] [Full Text] [Related]

  • 34. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y, Harada K, Ferdous T, Yoshida H.
    Anticancer Res; 2007 May 15; 27(4B):2365-75. PubMed ID: 17695527
    [Abstract] [Full Text] [Related]

  • 35. Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.
    Koschny R, Holland H, Sykora J, Haas TL, Sprick MR, Ganten TM, Krupp W, Bauer M, Ahnert P, Meixensberger J, Walczak H.
    Clin Cancer Res; 2007 Jun 01; 13(11):3403-12. PubMed ID: 17545549
    [Abstract] [Full Text] [Related]

  • 36. Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancer-binding protein homologous protein-dependent DR5 up-regulation.
    Kim EH, Yoon MJ, Kim SU, Kwon TK, Sohn S, Choi KS.
    Cancer Res; 2008 Jan 01; 68(1):266-75. PubMed ID: 18172319
    [Abstract] [Full Text] [Related]

  • 37. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes.
    Lin T, Gu J, Zhang L, Huang X, Stephens LC, Curley SA, Fang B.
    Cancer Res; 2002 Jul 01; 62(13):3620-5. PubMed ID: 12097263
    [Abstract] [Full Text] [Related]

  • 38. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas.
    Choi SA, Lee JY, Wang KC, Phi JH, Song SH, Song J, Kim SK.
    Eur J Cancer; 2012 Jan 01; 48(1):129-37. PubMed ID: 21664124
    [Abstract] [Full Text] [Related]

  • 39. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.
    Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, Yu JS.
    Cancer Res; 2002 Dec 15; 62(24):7170-4. PubMed ID: 12499252
    [Abstract] [Full Text] [Related]

  • 40. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model.
    Hong X, Miller C, Savant-Bhonsale S, Kalkanis SN.
    Neurosurgery; 2009 Jun 15; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 94.